Primary angiosarcomas of the breast

Area of Science:

• Oncology
• Surgical Pathology
• Medical Oncology

Background:

• Primary breast angiosarcoma is a rare and aggressive malignancy.
• Understanding its clinicopathologic features is crucial for effective management.

Purpose of the Study:

• To characterize the clinicopathologic features of primary breast angiosarcoma.
• To evaluate the clinical outcomes and survival of these patients.

Main Methods:

• Retrospective review of a single institution's database (1965-2002).
• Kaplan-Meier survival analysis and log-rank tests.
• Multivariate analysis using Cox proportional hazards models.

Main Results:

• 69 patients identified; median follow-up of 40 months.
• Advanced stage at diagnosis (median tumor size 5.5 cm) and rare lymph node metastasis.
• 5-year overall survival (OS) and recurrence-free survival (RFS) rates were 61% and 44%, respectively.
• Tumor size was the only significant factor associated with OS and RFS in multivariate analysis.
• Chemotherapy demonstrated a 48% response rate in the metastatic setting.

Conclusions:

• Breast angiosarcoma frequently presents advanced and has a propensity for local-regional recurrence.
• Chemotherapy can yield significant responses in metastatic disease.
• A multidisciplinary approach is recommended for high-risk patients, particularly those with large tumors.